Table 1—

Baseline characteristics of the diabetic cohort (n = 2,103) by CVD status

VariablesControl subjectsCase subjectsP
n1,719384
Sex (% men)62%63%0.80
Age (years)59 ± 361 ± 40.001
BMI (kg/m2)26 ± 328 ± 40.001
Waist circumference (cm)93 ± 1199 ± 130.001
Duration of diabetes (years)14 ± 316 ± 30.60
Diabetes treatment
    Diet only21150.20
    Oral hypoglycemic drugs62650.30
    Insulin only17200.20
Antihypertensive users60730.001
Aspirin users49480.80
Lipid-lowering users34360.60
Current smokers22230.70
Systolic blood pressure (mmHg)127 ± 12131 ± 160.001
Diastolic blood pressure (mmHg)80 ± 1283 ± 140.001
A1C (%)6.9 ± 0.87.3 ± 1.00.001
Triglycerides (mmol/l)1.32 ± 0.61.62 ± 1.00.001
HDL cholesterol (mmol/l)1.40 ± 0.31.32 ± 0.40.001
LDL cholesterol (mmol/l)3.35 ± 0.43.32 ± 0.50.80
AST (units/l)20 ± 626 ± 120.001
ALT (units/l)24 ± 632 ± 130.001
GGT (units/l)23 ± 1034 ± 140.001
Metabolic syndrome59750.001
NAFLD61960.001
  • Data are means ± SD or percentages unless otherwise indicated. Differences are assessed by the unpaired t test (for normally distributed variables) and by the χ2 test (for categorical variables). ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyl transferase.